Picture of DSM-Firmenich AG logo

DSFIR — DSM-Firmenich AG News Story

0.000.00%
nl flag iconLast trade - 00:00
IndustrialsBalancedLarge Cap

Brief: DSM-Firmenich Q4 Adjusted Ebitda EUR 408 Million Versus EUR 488 Million In Company Consensus

Feb 12 (Reuters) - DSM-Firmenich AG DSFIR.AS:

DSM-FIRMENICH REPORTS FULL YEAR 2025 RESULTS

Q4 ADJUSTED EBITDA INCLUDING DISCONTINUED OPERATIONS EUR 479 MLN VS EUR 488 MLN IN COMPANY CONSENSUS

Q4 SALES INCLUDING DISCONTINUED OPERATIONS EUR 2.941 BLN VS EUR 2.999 BLN IN COMPANY CONSENSUS

Q4 ORGANIC SALES GROWTH FROM CONTINUING OPERATIONS 2% VS 1.9% IN COMPANY CONSENSUS

TO MAINTAIN STABLE DIVIDEND OF EUR 2.50 PER SHARE

TO PROVIDE 2026 OUTLOOK AT INVESTOR EVENT ON MARCH 12

Source text: ID:nGNE6bTkMz

Further company coverage: DSFIR.AS

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on DSM-Firmenich AG

See all news